---
abstract: 'Population-based studies demonstrating the clinical impact of interferon-free direct-acting antiviral (DAA) therapies are lacking. We examined the impact of the introduction of DAAs on HCV-related decompensated cirrhosis (DC) through analysis of population-based data from Scotland.'
authors: ["Sharon Hutchinson", "Heather Valerio", "Scott McDonald", "admin", "Kevin Pollock", "Shanley Smith", "Stephen Barclay", "John Dillon", "Raymond Fox", "Peter Bramley", "Andrew Fraser", "Nicholas Kennedy", "Rory Gunson", "Kate Templeton", "Hamish Innes", "Allan McLeod", "Amanda Weir", "Peter Hayes", "David Goldberg"]
date: "2020-03-26"
doi: "10.1136/gutjnl-2019-320007"
featured: true
image:
  caption: ''
  focal_point: ""
projects: []
publication: '*Gut (BMJ)*'
publication_short: ""
publication_types:
- "2"
slides:
summary: We examined the impact of the introduction of direct-acting antiviral (DAA) therapies on hepatitis C related decompensated cirrhosis (DC) through analysis of population-based data from Scotland.
tags:
- HCV
- DAA
- Cirrhosis
title: 'Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study'
url_code: ""
url_dataset: ""
url_pdf: ""
url_poster: ""
url_project: ""
url_slides: ""
url_source: ""
url_video: ""
---
